Bevacizumab Approved for Another Type of Ovarian Cancer
The latest FDA approval is for use in patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. FDA Approvals …read more
Social isolation may lead to poor survival rates in breast cancer patients
New research suggests that socially isolated breast cancer survivors have higher rates of recurrence and mortality compared with socially integrated women. …read more